Marketing-authorisation holder · United States
Slate Run Pharma
1 medicine in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| SODIUM NITROPRUSSIDE10mg/50ml (0.2mg/ml) | 20mg/100ml (0.2mg/ml) | 50mg/100ml (0.5mg/ml) · Solution | Nitroprusside | United States | Marketed | 2022 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- slate run
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.